查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1540995

2024-2032 年按產品、應用（缺血性中風、動脈瘤、動靜脈畸形和瘻管、狹窄等）、最終用戶和地區分類的神經血管設備市場報告

Neurovascular Devices Market Report by Product, Application (Ischemic Stroke, Aneurysm, Arteriovenous Malformation and Fistulas, Stenosis, and Others), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2023年全球神經血管器械IMARC Group規模達29億美元。技術進步、神經血管疾病盛行率的增加、尋求微創治療的老年人口的增加以及醫療保健專業人員和研究機構之間的合作正在促進市場成長。

神經血管設備是一種醫療工具，旨在診斷和治療影響大腦和脊髓內血管和神經系統的疾病。它們採用先進材料和精密工程技術精心製作，以確保其安全性和有效性。它們透過實現微創手術來減少患者不適、住院時間和併發症，從而提供顯著的優勢。神經血管裝置廣泛應用於治療各種疾病，例如動脈瘤、動靜脈畸形和缺血性中風。神經血管裝置的類型包括支架、栓塞線圈、分流器和導管。支架可支持血管完整性，而栓塞彈簧圈則有助於阻止血流以治療動脈瘤。分流器用於引導血流遠離薄弱的血管區域，導管可以將治療直接輸送到受影響的區域。

全球神經血管設備市場受到醫療設備技術快速進步的影響，特別是在神經血管介入領域。此外，中風、動脈瘤和動靜脈畸形等疾病的盛行率不斷上升，需要創新和有效的治療方法，推動了市場的擴張。此外，全球老年人口的不斷增加，加上人們對神經血管疾病的認知不斷增強以及微創手術的普及，推動了市場的發展。與此一致，全球醫療保健基礎設施的發展也有助於提高神經血管治療的可近性，進一步推動市場成長。

神經血管設備市場趨勢/促進因素：

技術進步推動創新

在全球神經血管設備領域，關鍵的促進因素是技術進步的持續激增。醫療設備的創新徹底改變了神經血管干預，為各種神經血管疾病提供了新的治療途徑。 3D 列印、先進影像技術和微創手術等尖端技術重塑了病患照護的格局。這些創新可以實現更精確的診斷和治療，提高患者治療效果並降低風險。此外，將機器人技術和人工智慧整合到神經血管介入中，在最佳化手術和確保個人化治療方面具有巨大的潛力。隨著研發工作的持續進行，對技術進步的不懈追求推動了神經血管設備市場的發展勢頭，使其處於醫療創新的前沿。

神經血管疾病盛行率上升

全球神經血管設備市場的上升軌跡與神經血管疾病盛行率的上升有著內在的關聯。中風、動脈瘤和動靜脈畸形等疾病在全球範圍內構成了重大的健康挑戰。人口老化，加上生活方式和危險因子的改變，導致這些疾病的發生率更高。病例激增需要開發有效且先進的神經血管設備，以進行準確的診斷、治療和治療後監測。由於微創手術減少了患者不適並縮短了恢復時間，因此對微創手術的需求尤其突出。因此，市場透過創新設備和解決方案來滿足這種不斷成長的需求，並重申其作為改善患者治療結果和生活品質的重要參與者的地位。

老年人口和微創治療的可近性

老年人口是全球神經血管設備市場擴張的重要驅動力。隨著人口老化變得更容易受到神經血管疾病的影響，對全面和微創治療方案的需求不斷增加。老年人通常喜歡侵入性較小的手術，以最大限度地減少身體壓力和恢復時間。因此，製造商專注於開發適合該患者群體的設備，確保其安全性和有效性。微創治療的可用性不僅提高了患者的依從性，而且滿足了醫療保健產業對成本效益和高效干預措施的持續重視。老齡化人口的需求與市場產品之間的這種一致性鞏固了神經血管設備產業在滿足不斷變化的醫療保健需求方面的關鍵作用。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球神經血管設備市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 腦栓塞及動脈瘤彈簧圈裝置
    • 市場趨勢
    • 關鍵環節
      • 栓塞彈簧圈
      • 分流器
      • 液態栓塞劑
    • 市場預測
  • 腦血管成形術和支架系統
    • 市場趨勢
    • 關鍵環節
      • 頸動脈支架
      • 栓塞防護裝置
    • 市場預測
  • 神經血栓切除裝置
    • 市場趨勢
    • 關鍵環節
      • 血塊回收裝置
      • 吸引裝置
      • 血管圈套器
    • 市場預測
  • 支援設備
    • 市場趨勢
    • 關鍵環節
      • 微導管
      • 微型導絲
    • 市場預測

第 7 章：市場區隔：按應用

  • 缺血性中風
    • 市場趨勢
    • 市場預測
  • 動脈瘤
    • 市場趨勢
    • 市場預測
  • 動靜脈畸形和瘻管 (AVM)
    • 市場趨勢
    • 市場預測
  • 狹窄
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 門診手術中心
    • 市場趨勢
    • 市場預測
  • 診所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Acandis GmbH
    • Asahi Intecc Co. Ltd.
    • Imperative Care Inc.
    • Integer Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Penumbra Inc.
    • Perflow Medical Ltd.
    • Rapid Medical
    • Stryker Corporation
    • Terumo Corporation
Product Code: SR112024A6128

The global neurovascular devices market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.14% during 2024-2032. Technological advancements, increasing prevalence of neurovascular disorders, rising geriatric population seeking minimally invasive treatments, and collaborative efforts among healthcare professionals and research institutions are augmenting the market growth.

Neurovascular devices are medical tools designed to diagnose and treat conditions affecting the blood vessels and nervous system within the brain and spinal cord. They are carefully crafted using advanced materials and precision engineering techniques to ensure their safety and efficacy. They offer significant advantages by enabling minimally invasive procedures that reduce patient discomfort, hospitalization times, and complications. Neurovascular devices find extensive application in addressing various conditions, such as aneurysms, arteriovenous malformations, and ischemic strokes. The types of neurovascular devices include stents, embolic coils, flow diverters, and catheters. Stents support blood vessel integrity, while embolic coils help block blood flow to treat aneurysms. Flow diverters are used to redirect blood flow away from weakened vessel areas, and catheters enable the delivery of treatments directly to affected areas.

The global neurovascular devices market is influenced by rapid technological advancements in medical devices, particularly in the field of neurovascular interventions. Moreover, the rising prevalence of conditions such as strokes, aneurysms, and arteriovenous malformations necessitates the demand for innovative and effective treatment approaches, fueling the market's expansion. Additionally, the increasing geriatric population worldwide, coupled with a growing awareness of neurovascular diseases and the availability of minimally invasive procedures, propels the market forward. In line with this, the healthcare infrastructure development globally also contributes to enhanced accessibility to neurovascular treatments, further propelling market growth.

Neurovascular Devices Market Trends/Drivers:

Technological advancements driving innovation

In the realm of global neurovascular devices, a pivotal driver is the continuous surge in technological advancements. Innovations in medical devices have revolutionized neurovascular interventions, presenting novel treatment avenues for various neurovascular disorders. Cutting-edge technologies such as 3D printing, advanced imaging techniques, and minimally invasive procedures have reshaped the landscape of patient care. These innovations enable more precise diagnosis and treatment, enhancing patient outcomes and reducing risks. Moreover, the integration of robotics and artificial intelligence into neurovascular interventions holds immense potential for optimizing procedures and ensuring personalized treatments. As research and development efforts persist, the relentless pursuit of technological progress fuels the momentum of the neurovascular devices market, establishing it at the forefront of medical innovation.

Rising prevalence of neurovascular disorders

The upward trajectory of the global neurovascular devices market is intrinsically linked to the rising prevalence of neurovascular disorders. Conditions such as strokes, aneurysms, and arteriovenous malformations pose significant health challenges on a global scale. The aging population, coupled with changing lifestyles and risk factors, has contributed to a higher incidence of these disorders. This surge in cases necessitates the development of effective and advanced neurovascular devices for accurate diagnosis, treatment, and post-treatment monitoring. The demand for minimally invasive procedures has particularly gained prominence due to their reduced patient discomfort and quicker recovery times. Consequently, the market responds to this growing need with innovative devices and solutions, reaffirming its position as a vital player in improving patient outcomes and quality of life.

Geriatric population and accessibility to minimally invasive treatments

The geriatric demographic stands as a significant driver in the expansion of the global neurovascular devices market. With the aging population becoming more susceptible to neurovascular disorders, the demand for comprehensive and minimally invasive treatment options escalates. Older individuals often prefer less invasive procedures that minimize physical stress and recovery times. As a result, manufacturers focus on developing devices tailored to this patient group, ensuring their safety and efficacy. The availability of minimally invasive treatments not only improves patient compliance but also addresses the healthcare industry's ongoing emphasis on cost-effective and efficient interventions. This alignment between the needs of the aging population and the market's offerings solidifies the neurovascular devices sector's crucial role in catering to evolving healthcare demands.

Neurovascular Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global neurovascular devices market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

Cerebral Embolization and Aneurysm Coiling Devices

Embolic Coils

Flow Diverters

Liquid Embolic Agents

Cerebral Angioplasty and Stenting Systems

Carotid Artery Stents

Embolic Protection Devices

Neurothrombectomy Devices

Clot Retrieval Devices

Suction Devices

Vascular Snares

Support Devices

Micro Catheters

Micro Guidewires

Cerebral embolization and aneurysm coiling devices dominate the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes cerebral embolization and aneurysm coiling devices (embolic coils, flow diverters, and liquid embolic agents), cerebral angioplasty and stenting systems (carotid artery stents and embolic protection devices), neurothrombectomy devices (clot retrieval devices, suction devices, and vascular snares), and support devices (micro catheters and micro guidewires). According to the report, cerebral embolization and aneurysm coiling devices represented the largest segment.

The growth of the cerebral embolization and aneurysm coiling devices segment can be attributed to several key factors that collectively shape its trajectory. Technological advancements play a pivotal role, with continuous innovations enhancing the efficacy and safety of these devices. As medical technologies evolve, cerebral embolization and aneurysm coiling devices are becoming more sophisticated, allowing for more precise interventions and improved patient outcomes. Moreover, the increasing incidence of cerebral aneurysms and related disorders drives demand for advanced treatment options, fostering the adoption of coiling devices. Minimally invasive procedures have gained traction due to their reduced patient discomfort and quicker recovery times, further fueling the segment's growth. Additionally, rising awareness among healthcare professionals and patients regarding the benefits of early intervention and minimally invasive techniques contributes to expanded usage of these devices.

Breakup by Application:

Ischemic Stroke

Aneurysm

Arteriovenous Malformation and Fistulas (AVM)

Stenosis

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes ischemic stroke, aneurysm, arteriovenous malformation and fistulas (AVM), stenosis, and others.

Within the ischemic stroke segment, the surge in global incidences, especially among the aging population, fuels demand for advanced interventions. Technological strides enable swift diagnoses and targeted treatments, while thrombectomy procedures and clot retrieval devices enhance patient outcomes. The aneurysm segment thrives due to surging awareness of risks, spurring demand for effective treatments. Innovations like flow diverters and collaboration among medical professionals amplify growth. Similarly, the arteriovenous malformation and fistulas (AVM) segment benefits from precise imaging, minimally invasive methods, and collaborative efforts. The stenosis segment, on the other hand, is driven by the need for advanced interventions and technological progress and early interventions. Furthermore, the others segment evolves through tailored technological solutions, collaborative research, and growing global awareness, underscoring its contribution to the neurovascular devices market's overall expansion.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Clinics

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, clinics, and others. According to the report, hospitals represented the largest segment.

The growth of the hospitals segment within the neurovascular devices market can be attributed to the advancements in medical technology that have significantly enhanced the quality of patient care provided by hospitals. Cutting-edge diagnostic tools, surgical instruments, and treatment methods enable hospitals to offer state-of-the-art medical services, attracting patients seeking the latest and most effective treatments. Additionally, the increasing prevalence of chronic diseases and the aging population drives the demand for specialized medical care, further boosting hospital growth. Moreover, the role of hospitals as centers of medical expertise and comprehensive care fosters their growth. Patients often prefer hospitals for their ability to provide a wide range of medical services under one roof, including diagnostics, surgery, rehabilitation, and specialized treatments. This integrated approach enhances patient convenience and healthcare outcomes, positioning hospitals as trusted destinations for healthcare needs. Furthermore, strategic partnerships and collaborations between hospitals and pharmaceutical companies, medical device manufacturers, and research institutions fuel growth.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest neurovascular devices market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The growth of the neurovascular devices market in North America is underpinned by a robust healthcare infrastructure, coupled with advanced medical technology. The region's strong focus on research and development fosters the creation of cutting-edge devices, driving the market's expansion. In line with this, the increasing prevalence of neurovascular disorders, attributed to factors such as lifestyle changes and an aging population, elevates the demand for effective treatment solutions. Furthermore, heightened awareness of the importance of early diagnosis and intervention among both healthcare professionals and the general public contributes to market growth. Additionally, strategic collaborations between industry players, research institutions, and healthcare providers propel the development of groundbreaking neurovascular devices. Regulatory bodies' support for swift approval processes and the region's favorable reimbursement policies facilitates market accessibility. The presence of skilled healthcare professionals and a patient-centric approach further accentuate the adoption of neurovascular interventions.

Competitive Landscape:

The competitive landscape of the global neurovascular devices market showcases a dynamic and evolving environment driven by innovation and strategic initiatives. Industry players are engaged in continuous research and development efforts to introduce advanced devices that cater to the increasing demand for effective neurovascular interventions. Collaborative ventures between manufacturers, research institutions, and healthcare providers amplify the development of cutting-edge solutions. Mergers and acquisitions within the market enhance product portfolios, distribution networks, and market reach. Moreover, the emphasis on regulatory compliance and adherence to quality standards ensures the delivery of safe and efficacious devices.

As the market gains traction, the competitive landscape is also influenced by factors such as pricing strategies, product differentiation, and customer support. Companies seek to establish themselves as thought leaders by actively participating in conferences, publishing research findings, and engaging in knowledge-sharing activities. This approach aims to position them as trusted experts in the neurovascular domain. In this ever-evolving arena, the competitive landscape remains a dynamic interplay of innovation, strategic collaborations, and efforts to establish a distinct market presence.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Acandis GmbH

Asahi Intecc Co. Ltd.

Imperative Care Inc.

Integer Holdings Corporation

Johnson & Johnson

Medtronic plc

MicroPort Scientific Corporation

Penumbra Inc.

Perflow Medical Ltd.

Rapid Medical

Stryker Corporation

Terumo Corporation

Recent Developments:

In July 2023, Rapid Medical announced new clinical data demonstrating the "significant advantages" of its novel Comaneci embolisation assist device to treat ruptured wide-neck intracranial aneurysms.

In July 2023, Johnson & Johnson announced its intention to split-off at least 80.1% of the shares of Kenvue Inc. through an exchange offer.

In May 2023, Stryker Corporation acquired Cerus Endovascular. The company is involved in the design, development, manufacture and supply of interventional neurovascular devices and delivery systems used by neuroradiologists for treating intracranial aneurysms.

Key Questions Answered in This Report

  • 1. What was the size of the global neurovascular devices market in 2023?
  • 2. What is the expected growth rate of the global neurovascular devices market during 2024-2032?
  • 3. What are the key factors driving the global neurovascular devices market?
  • 4. What has been the impact of COVID-19 on the global neurovascular devices market?
  • 5. What is the breakup of the global neurovascular devices market based on the product?
  • 6. What is the breakup of the global neurovascular devices market based on end user?
  • 7. What are the key regions in the global neurovascular devices market?
  • 8. Who are the key players/companies in the global neurovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurovascular Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cerebral Embolization and Aneurysm Coiling Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Embolic Coils
      • 6.1.2.2 Flow Diverters
      • 6.1.2.3 Liquid Embolic Agents
    • 6.1.3 Market Forecast
  • 6.2 Cerebral Angioplasty and Stenting Systems
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Carotid Artery Stents
      • 6.2.2.2 Embolic Protection Devices
    • 6.2.3 Market Forecast
  • 6.3 Neurothrombectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Clot Retrieval Devices
      • 6.3.2.2 Suction Devices
      • 6.3.2.3 Vascular Snares
    • 6.3.3 Market Forecast
  • 6.4 Support Devices
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Micro Catheters
      • 6.4.2.2 Micro Guidewires
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Ischemic Stroke
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Aneurysm
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Arteriovenous Malformation and Fistulas (AVM)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Stenosis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Acandis GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Asahi Intecc Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Imperative Care Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Integer Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Johnson & Johnson
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Medtronic plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 MicroPort Scientific Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Penumbra Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perflow Medical Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rapid Medical
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Neurovascular Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurovascular Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Neurovascular Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Neurovascular Devices Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Neurovascular Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Neurovascular Devices Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Neurovascular Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Neurovascular Devices (Cerebral Embolization and Aneurysm Coiling Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Neurovascular Devices (Cerebral Embolization and Aneurysm Coiling Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Neurovascular Devices (Cerebral Angioplasty and Stenting Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Neurovascular Devices (Cerebral Angioplasty and Stenting Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Neurovascular Devices (Neurothrombectomy Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Neurovascular Devices (Neurothrombectomy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Neurovascular Devices (Support Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Neurovascular Devices (Support Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Neurovascular Devices (Ischemic Stroke) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Neurovascular Devices (Ischemic Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Neurovascular Devices (Aneurysm) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Neurovascular Devices (Aneurysm) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Neurovascular Devices (Arteriovenous Malformation and Fistulas (AVM)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Neurovascular Devices (Arteriovenous Malformation and Fistulas (AVM)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Neurovascular Devices (Stenosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Neurovascular Devices (Stenosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Neurovascular Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Neurovascular Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Neurovascular Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Neurovascular Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Neurovascular Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Neurovascular Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Neurovascular Devices (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Neurovascular Devices (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Neurovascular Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Neurovascular Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Neurovascular Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Neurovascular Devices Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Neurovascular Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Neurovascular Devices Industry: SWOT Analysis
  • Figure 84: Global: Neurovascular Devices Industry: Value Chain Analysis
  • Figure 85: Global: Neurovascular Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurovascular Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Neurovascular Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Neurovascular Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Neurovascular Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Neurovascular Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Neurovascular Devices Market: Competitive Structure
  • Table 7: Global: Neurovascular Devices Market: Key Players